Series A round for revolutionary tissue diagnostics company Lunaphore

VISCHER advises investors in the seed financing in Lunaphore Technologies SA, in Lausanne, a medical device spin-off from EPFL Lausanne. Lunaphore has developed an innovative tissue diagnostics platform, primarily for analysis and classification of tumors. The platform is based on a microfluidic chip technology that allows fine-tuning of such diagnostic assays and increases their speed and accuracy. The VISCHER Team is led by Dr. Matthias Staehelin (Partner) with Moritz Jäggy (Associate), both Corporate.

Moritz Jäggy

Attorney at Law

• Partner

• +41 58 211 32 33
• [email protected]

Matthias Staehelin

Attorney at Law and Civil Law Notary (BS/BL)

• Partner

• +41 58 211 33 53
• [email protected]